SSCA
IDXX icon

South Shore Capital Advisors’s Idexx Laboratories IDXX Stock Holding History

South Shore Capital Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$363K Buy
690
+64
+10% +$35.9K 0.24% 93
2026
Q1 		$352K Buy
+626
New +$401K 0.26% 86

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

South Shore Capital Advisors's IDXX Position: Q2 2026 in Review

South Shore Capital Advisors increased its Idexx Laboratories (IDXX) stake by 10% in Q2 2026, buying an estimated $35.9K and bringing the position to 690 shares worth $363K. The position accounts for 0.24% of the portfolio, ranked #93.

South Shore Capital Advisors first reported a position in IDXX in Q1 2026 and has held it in 2 quarters since. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • South Shore Capital Advisors held 690 shares of Idexx Laboratories worth $363K as of Q2 2026.
  • South Shore Capital Advisors bought 64 Idexx Laboratories shares in Q2 2026, an estimated $35.9K.
  • Idexx Laboratories made up 0.24% of South Shore Capital Advisors's portfolio in Q2 2026, its #93 holding.
  • South Shore Capital Advisors first reported a position in Idexx Laboratories in Q1 2026 and has held it in 2 quarters since.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on South Shore Capital Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.